PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY, Mai Y, Shah UA, Wei Y, Ishida E, Kataoka K, Ren X, Pradhan K, Bartholdy B, Wei X, Zou Y, Zhang J, Ogawa S, Steidl U, Zang X, Verma A, Janakiram M, Ye BH.
Chung EY, et al. Among authors: zang x.
Clin Cancer Res. 2019 Jun 15;25(12):3589-3601. doi: 10.1158/1078-0432.CCR-18-3033. Epub 2019 Mar 12.
Clin Cancer Res. 2019.
PMID: 30862694